Key Clinical Takeaways for Patients & Caregivers
Essential points vetted by senior oncologists regarding this clinical protocol
-
Early Symptom Identification: Numbness, tingling, or "pins and needles" in the toes and fingertips should be reported immediately to prevent permanent axonal damage.
-
Neuro-Protective Cryotherapy: Wearing frozen gloves and socks during neurotoxic chemotherapy infusions significantly reduces drug delivery to peripheral extremities.
-
Evidence-Based Medications: Duloxetine and gabapentinoids provide established relief for cancer neuropathy discomfort.
-
Home Safety Precautions: Wear supportive footwear, check bath water temperature with a thermometer, and remove loose floor rugs to prevent falls.
In This Article (Table of Contents)
01. Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Certain neurotoxic chemotherapy agents—notably taxanes (Paclitaxel, Docetaxel), platinum compounds (Oxaliplatin, Cisplatin), and vinca alkaloids (Vincristine)—damage distal sensory axons and dorsal root ganglia in a characteristic "glove-and-stocking" distribution.
Patients experience symmetrical tingling, burning sensations, motor weakness, and reduced proprioception, which impairs fine motor tasks like buttoning shirts or walking steadily.
02. Cryotherapy Protocols & Pharmacological Interventions
Applying hypothermic gloves and socks cooled to -20°C for 15 minutes before, during, and after paclitaxel infusions causes local vasoconstriction, reducing microvascular drug exposure to peripheral nerves by up to 50%.
For established neuropathic pain, Duloxetine (30–60 mg daily) is the only agent recommended with Level-1 clinical trial evidence by the American Society of Clinical Oncology (ASCO).
